Comparison of Synchronous and Asynchronous Action Observation Therapy in Children With Cerebral Palsy
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Aug 8, 2025
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Cerebral palsy (CP) is defined as a non-progressive neurological disorder that arises during fetal development, the neonatal period, or early childhood and results in permanent motor impairments. Lesions in the central nervous system of children with CP lead to a range of musculoskeletal, neuromuscular, and sensory system problems, causing postural abnormalities, balance and coordination deficits, and limitations in mobility. These impairments significantly reduce independence in activities of daily living.
Various therapeutic approaches are utilized in the rehabilitation process to improv...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntary participation of both the child and their family in the study
- • Diagnosis of cerebral palsy with spastic clinical type, including hemiparetic and diparetic distribution
- • Age between 6 and 18 years
- • Classified as Level I or II according to the Gross Motor Function Classification System (GMFCS)
- • Ability to comply with exercise interventions (based on medical report indicating normal mental level or "mild mental retardation")
- • Ability to understand and speak Turkish
- Exclusion Criteria:
- • Presence of spasticity ≥3 in lower extremity muscle groups as measured by the Modified Ashworth Scale
- • Inability to cooperate with verbal commands
- • Presence of visual or hearing impairments
- • Diagnosis of epilepsy or current use of antiepileptic medications
- • Presence of joint contractures
- • Botulinum toxin injection to the lower extremities within the past 6 months
- • Undergoing orthopedic surgery within the past 6 months
- • Presence of any additional systemic or neurological diseases
- • Missing three consecutive rehabilitation sessions
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported